Premium
Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma
Author(s) -
Cavalieri Stefano,
Licitra Lisa
Publication year - 2020
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32971
Subject(s) - medicine , nasopharyngeal carcinoma , induction chemotherapy , chemotherapy , oncology , radiation therapy , carcinoma
NPC‐0501 has shown that induction chemotherapy provides a survival benefit for patients with locoregionally advanced nasopharyngeal carcinoma and has added evidence to current knowledge. In the intensity‐modulated radiotherapy era, neoadjuvant chemotherapy should be considered at least for patients with high‐risk disease.